Surmodics, Inc.
SRDX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,542 | -$1,536 | -$27,274 | $4,237 |
| Dep. & Amort. | $8,694 | $8,522 | $9,142 | $8,017 |
| Deferred Tax | -$320 | -$181 | $5,268 | $1,651 |
| Stock-Based Comp. | $8,217 | $7,605 | $7,057 | $5,863 |
| Change in WC | -$5,359 | -$4,236 | -$12,276 | -$4,857 |
| Other Non-Cash | $558 | $340 | $860 | $478 |
| Operating Cash Flow | $248 | $10,514 | -$17,223 | $15,389 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,492 | -$2,918 | -$3,370 | -$6,279 |
| Net Acquisitions | $0 | $0 | $0 | -$39,553 |
| Inv. Purchases | -$25,445 | -$3,904 | $0 | -$22,723 |
| Inv. Sales/Matur. | $26,000 | $0 | $9,600 | $43,317 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,937 | -$6,822 | $6,230 | -$25,238 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $19,664 | $0 | $10,000 |
| Stock Issued | $1,216 | $1,252 | $1,246 | $3,128 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$4,166 | -$2,510 | -$1,621 | -$2,901 |
| Financing Cash Flow | -$2,950 | $18,406 | -$375 | $10,227 |
| Forex Effect | $335 | $323 | -$787 | -$10 |
| Net Chg. in Cash | -$5,304 | $22,421 | -$12,155 | $368 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,419 | $18,998 | $31,153 | $30,785 |
| End Cash | $36,115 | $41,419 | $18,998 | $31,153 |
| Free Cash Flow | -$3,244 | $7,596 | -$20,593 | $9,110 |